NFKB1 and early-onset autosomal dominant Alzheimer disease: Dysregulated NF-κB activation has been linked with various inflammatory disease states, including Alzheimer’s disease, arthritis, asthma, atherosclerosis, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and inflammatory bowel disease [30].